From Advocacy to Access: Mito Community Celebrates FDA Milestone
Barth syndrome therapy sets precedent for future treatments targeting mitochondrial dysfunction In a landmark decision, the U.S. Food and Drug […]
IMP Launches New TK2d Video
IMP Launches New TK2d Video To mark TK2d Awareness Day 2025, we’ve released a new video that amplifyies the voices
IMP Welcomes Three New Members
IMP now has members across three continents We’re delighted to welcome three new members to IMP. With these new members,